Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
6.00
-0.15 (-2.44%)
Jun 27, 2025, 4:00 PM - Market closed
Profound Medical Stock Forecast
Stock Price Forecast
The 2 analysts that cover Profound Medical stock have a consensus rating of "Strong Buy" and an average price target of $11.5, which forecasts a 91.67% increase in the stock price over the next year. The lowest target is $11 and the highest is $12.
Price Target: $11.5 (+91.67%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 23, 2025.
Analyst Ratings
The average analyst rating for Profound Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $17 → $11 | Strong Buy | Maintains | $17 → $11 | +83.33% | Apr 23, 2025 |
| Stifel | Stifel | Hold → Strong Buy Upgrades $9 → $12 | Hold → Strong Buy | Upgrades | $9 → $12 | +100.00% | Jul 16, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $13 → $11 | Strong Buy | Maintains | $13 → $11 | +80.00% | Mar 11, 2024 |
| Stifel | Stifel | Hold Maintains $11 → $9 | Hold | Maintains | $11 → $9 | +50.00% | Mar 8, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +112.50% | Jan 4, 2024 |
Financial Forecast
Revenue This Year
18.28M
from 10.68M
Increased by 71.17%
Revenue Next Year
42.82M
from 18.28M
Increased by 134.25%
EPS This Year
-1.12
from -1.12
EPS Next Year
-0.87
from -1.12
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.0M | 50.9M | 60.6M | ||
| Avg | 18.3M | 42.8M | 58.3M | ||
| Low | 16.7M | 35.6M | 56.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 86.8% | 178.6% | 41.5% | ||
| Avg | 71.2% | 134.3% | 36.1% | ||
| Low | 56.0% | 94.6% | 32.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.11 | -0.62 | -1.20 | ||
| Avg | -1.12 | -0.87 | -1.15 | ||
| Low | -1.14 | -1.12 | -1.12 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.